Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
11 participants
INTERVENTIONAL
2018-09-04
2019-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Baby Bump Lifestyle Intervention Supplement Study
NCT03751813
A Low Glycemic Load Diet During Pregnancy in Overweight Women
NCT00364403
Pregnancy Tracking Pilot
NCT04025892
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
NCT00550979
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
NCT01875107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
100 g carbs
100 grams of carbohydrate allowance for the day
100 g carbs
Participants will be assigned a diet of 100g carbs max for the day
MyPlate
Carbohydrate suggestions based on standard MyPlate. 45-65% kcal intake from carbs.
MyPlate
40-65% of daily intake is from carbohydrates
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
100 g carbs
Participants will be assigned a diet of 100g carbs max for the day
MyPlate
40-65% of daily intake is from carbohydrates
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 30 and/or history of gestational diabetes mellitus
* Currently in first trimester of pregnancy with single fetus (e.g. not twins, triplets, etc.)
* Newborns of current participants
Exclusion Criteria
* History of major chronic disease or blood clotting disorders (e.g., cancer, heart disease, kidney disease, hypertension)
* Known fetal anomaly
* History of eating disorders
* Current use of medications that affect appetite or insulin secretion/sensitivity (e.g. stimulants)
* Current use of illegal substances, antipsychotic or opioid substitution medications, alcohol, or tobacco
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kai Ling Kong
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kai Ling Kong, PhD
Role: PRINCIPAL_INVESTIGATOR
SUNY Buffalo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SUNY Buffalo
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00002745
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.